To conduct phase i, II, III, or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N94020D00021
- Awardee
-
University Of Utah UEI LL8GLEVH6MG3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $696,146 obligated
Award facts
- Opportunity
-
- Contraceptive Development Program NICHD Contraceptive Clinical Trials Network Female Sites Pre-Solicitation · NIHNICHDCDP20201 · Posted May 7, 2019
- Contraceptive Development Program NICHD Contraceptive Clinical Trials Network Female Sites Solicitation · Posted Aug 9, 2019
- Combined order value
-
- $696,146 Current, with exercised options
- $880,086 Potential, with all options
- Last date to order 89% complete
- IDV ceiling 14% used
- $5,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Child Health and Human Development awarded a multiple-award indefinite-delivery contract to University of Utah for $5 million on August 1, 2020, with an ultimate completion date of July 31, 2027. Performance occurs in Salt Lake City, Utah.
The IDIQ funds Phase I, II, III, or IV contraceptive clinical trials in women, treatment trials of gynecologic conditions including endometriosis and leiomyomata, and development of research protocols on a task-order basis.
Recent task-order activity includes a $682,758.40 cost-type delivery order issued August 1, 2025 for Phase 2B clinical trial services under the Collaborative Centers Treatment Network Laboratory-Based program, with completion by March 31, 2029. A $141,890 cost-plus-fixed-fee delivery order for the Ovaprene vaginal device clinical trial protocol finalization, regulatory approval, and recruitment commencement was issued September 28, 2023, with completion by December 31, 2025. A core task order valued at $55,437.23 issued August 1, 2020 supports protocol review, protocol development, and CCTN activities through July 31, 2027.
Description
To conduct phase i, II, III, or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis under a seven (7) year indefinite-delivery
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N94020D00021?
75N94020D00021 was awarded to University Of Utah by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.
How much is contract 75N94020D00021 worth?
Orders under 75N94020D00021 have obligated $696,146. Their combined potential value, with all options, is $880,086. 75N94020D00021's own ceiling is $5,000,000.
How many orders have been placed under contract 75N94020D00021?
3 orders have been placed under 75N94020D00021, the latest on August 1, 2025.
Who can order from contract 75N94020D00021?
75N94020D00021 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N94020D00021 competed?
The extent of competition for 75N94020D00021 was full and open competition. The government received 18 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV